In drug-resistant pancreatic cancer cells, the expression level of miR-30a-5p was even lower (p < 0.05) (Fig. 6e) and the expression level of CD73 was higher (p < 0.05) (Fig. 6f). This evidence concerns the gene NT5E and familial pancreatic carcinoma.